TOP  >  Personal Info.
OKUYAMA, Ryo Professor
Knowledge Science, Transformative Knowledge Management
◆Degrees
Ph.D. in Management of Technology Tokyo Institute of Technology
Ph.D. in Pharmaceutical Sciences The University of Tokyo
◆Professional Experience
2024 - 2025 : Ritsumeikan Asia Pacific University , 社会連携部長
2022 - 2025 : Ritsumeikan Asia Pacific University , College of International Management , 教授
2020 - 2022 : DaiichiSankyo Co., Ltd. , Specialty Medicine Research Global Head
2019 - 2022 : DaiichiSankyo Co., Ltd. , Specialty Medicine Research Laboratories II , Vice President
2018 - 2019 : DaiichiSankyo Co., Ltd. , End-Organ Disease Laboratories , Vice President
2015 - 2018 : DaiichiSankyo Co., Ltd. , Research Planning, Research Function , Senior Director
2010 - 2015 : DaiichiSankyo Co., Ltd. , Cardiovascular-Metabolics Research Laboratories , Senior Director
2007 - 2010 : DaiichiSankyo Co., Ltd. , Associate Senior Researcher - Senior Researcher
1998 - 2001 : Hexos Inc. , Visiting Scientist
1993 - 2007 : Sankyo Co., Ltd. , Researcher - Associate Senior Researcher
◆Specialties
Business administration, Pharmacology
◆Research Keywords
drug discovery, new drug R&D, technology management, innovation, startup, university-industry-government collaboration, ecosystem, deep-tech

■Publications

◆Published Papers
Revitalizing Japan's biomedical ecosystem: Policy initiatives, challenges, and future directions.
Ryo Okuyama
Drug Discoveries & Therapeutics, 19, 4, 214-219, 2025
Toward Establishing a Japanese Drug Discovery Ecosystem: The Role of Startups and a Model Tailored to Japan.
Ryo Okuyama
YAKUGAKU ZASSHI, 145, 7, 617-628, 2025
National Granted Programs and Public Funds for Biopharmaceutical Startups in Japan.
Ryo Okuyama
Pharmacology Research & Perspectives, 13, e70106-, 2025
Leveraging Corporate Assets and Talent to Attract Investors in Japan: A Country with an Innovation System Centered on Large Companies.
Ryo Okuyama
Journal of Risk and Financial Management, 17, 12, 539-, 2024
Developer and Partnership Differences in COVID-19 and Other Infections: Insights from DNA Vaccines.
Ryo Okuyama
Journal of Market Access & Health Policy, 12, 4, 317-325, 2024
◆Books
Chapter 3. Drug Repurposing for Psychiatric Diseases. In Drug Repurposing: Chemistry, Biochemistry & Red Biotechnology (Ed.M.N.Gupta)
分担執筆, 44-61, CRC Press (Taylor & Francis group), 2025
サイエンス･ベースド･イノベーション－ディープテックのマネジメント－
単著, 時潮社, 2020
◆Conference Activities & Talks
日本のトランスレーショナルリサーチの現況と日米比較（マンスフィールド-PhRMA研究者プログラム オンラインレクチャー）
マンスフィールド-PhRMA研究者プログラム, マンスフィールド財団, 2025
An attempt to analyze Japanese technology startups using a large-scale database
Asia Pacific Conference 2024, 2024
日本の創薬イノベーションエコシステムの概況
研究・イノベーション学会 第３９回年次学術大会, 研究・イノベーション学会, 2024
大学発創薬を巡る日本の状況と期待 (AMED BINDSシンポジウム2024)
AMED BINDSシンポジウム2024, 国立研究開発法人日本医療研究開発機構（AMED） 創薬事業部 医薬品研究開発課, 2024
Innovation System for Drug Discovery in Japan: Current Status, Challenges and Solutions
The 39th Annual Meeting of the Academy of Pharmaceutical Science and Technology, Japan, Academy of Pharmaceutical Science and Technology, Japan (APSTJ), 2024

■Contributions to  Society

◆Academic Contribution
会計理事 , 一般社団法人 研究・イノベーション学会

■Academic  Awards

・ AY2024 Research Award , Ritsumeikan Asia Pacific University , 2025
・ AY2023 Research Excellence Award , Ritsumeikan Asia Pacific University , 2024
・ AY2022 Research Award , Ritsumeikan Asia Pacific University , 2023